22-40404612-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The ENST00000248929.14(SGSM3):āc.422A>Gā(p.Tyr141Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,618 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00011 ( 0 hom., cov: 33)
Exomes š: 0.000010 ( 1 hom. )
Consequence
SGSM3
ENST00000248929.14 missense
ENST00000248929.14 missense
Scores
13
4
2
Clinical Significance
Conservation
PhyloP100: 8.89
Genes affected
SGSM3 (HGNC:25228): (small G protein signaling modulator 3) Enables GTPase activator activity and small GTPase binding activity. Involved in several processes, including Rap protein signal transduction; positive regulation of GTPase activity; and regulation of Rab protein signal transduction. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.937
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGSM3 | NM_015705.6 | c.422A>G | p.Tyr141Cys | missense_variant | 6/22 | ENST00000248929.14 | NP_056520.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGSM3 | ENST00000248929.14 | c.422A>G | p.Tyr141Cys | missense_variant | 6/22 | 1 | NM_015705.6 | ENSP00000248929 | P1 | |
SGSM3 | ENST00000457767.5 | c.221A>G | p.Tyr74Cys | missense_variant | 5/8 | 2 | ENSP00000399249 | |||
SGSM3 | ENST00000478085.5 | n.399A>G | non_coding_transcript_exon_variant | 2/9 | 2 | |||||
SGSM3 | ENST00000485962.5 | n.583A>G | non_coding_transcript_exon_variant | 6/20 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152114Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
16
AN:
152114
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250752Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135578
GnomAD3 exomes
AF:
AC:
2
AN:
250752
Hom.:
AF XY:
AC XY:
1
AN XY:
135578
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461504Hom.: 1 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727044
GnomAD4 exome
AF:
AC:
15
AN:
1461504
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
727044
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000105 AC: 16AN: 152114Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74290
GnomAD4 genome
AF:
AC:
16
AN:
152114
Hom.:
Cov.:
33
AF XY:
AC XY:
9
AN XY:
74290
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.422A>G (p.Y141C) alteration is located in exon 6 (coding exon 5) of the SGSM3 gene. This alteration results from a A to G substitution at nucleotide position 422, causing the tyrosine (Y) at amino acid position 141 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;H
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
1.0
.;D
Vest4
0.97
MutPred
0.80
.;Loss of phosphorylation at Y141 (P = 0.0203);
MVP
MPC
0.75
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at